Safety of using genetic engineering biological agents in rheumatoid arthritis
The paper reviews the current trials of the safety of using genetic engineering biological agents (GEBA) in patients with rheumatoid arthritis. It is stated that before its start, GEBA therapy calls for thorough screening of patients to rule out communicable diseases (including tuberculosis) or a hi...
| 发表在: | Современная ревматология |
|---|---|
| Main Authors: | , |
| 格式: | 文件 |
| 语言: | 俄语 |
| 出版: |
IMA-PRESS LLC
2010-03-01
|
| 主题: | |
| 在线阅读: | https://mrj.ima-press.net/mrj/article/view/272 |